These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6799484)

  • 1. Bactericidal activity of SQ 26776.
    Shah PM; Losert-Brüggner B; Stille W
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():77-80. PubMed ID: 6799484
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibacterial activity of a monocyclic beta-lactam SQ 26,776.
    Neu HC; Labthavikul P
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():111-22. PubMed ID: 6799479
    [No Abstract]   [Full Text] [Related]  

  • 3. In-vitro activity of the monobactam, SQ 26,776, against Gram-negative bacteria and its stability to their beta-lactamases.
    Livermore DM; Williams JD
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():29-37. PubMed ID: 6799480
    [No Abstract]   [Full Text] [Related]  

  • 4. In-vitro antibacterial activity of SQ 26,776.
    Norrby R; Friberg K; Holm SE
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():69-76. PubMed ID: 7199045
    [No Abstract]   [Full Text] [Related]  

  • 5. In-vitro activity of monobactam, SQ 26,776, against Gram-negative bacteria.
    Percival A; Thomas E; Hart CA; Karayiannis P
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():49-55. PubMed ID: 6799482
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibacterial activity of the monobactam SQ 26,776 against antibiotic resistant enterobacteria, including Serratia spp.
    Reeves DS; Bywater MJ; Holt HA
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():57-68. PubMed ID: 6799483
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vitro activity of azthreonam (SQ 26.776) against Gram-negative bacteria].
    Landínez RJ; García Castro MA; Coladas N; Bratos MA; Kastanos N; Alvarez Alonso E
    Med Clin (Barc); 1984 Jan; 82(3):106-9. PubMed ID: 6431206
    [No Abstract]   [Full Text] [Related]  

  • 8. Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam.
    Dudley MN; Ambrose PG; Bhavnani SM; Craig WA; Ferraro MJ; Jones RN;
    Clin Infect Dis; 2013 May; 56(9):1301-9. PubMed ID: 23334813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro study of antibacterial activity of cefepime (Axepim) against gram negative bacteria: comparison with cephalosporins and other beta-lactams].
    Vachée A; Devalckenaere A; Husson MO; Izard D
    Pathol Biol (Paris); 1996 Feb; 44(2):132-7. PubMed ID: 8761598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Computerized analysis of activity profiles of beta-lactams].
    Pitton JS; Philippin JL; Fournier P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):581-5. PubMed ID: 3937131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agents.
    Wise R; Andrews JM; Hancox J
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():39-47. PubMed ID: 6799481
    [No Abstract]   [Full Text] [Related]  

  • 12. In-vitro activity of the monobactam Ro 17-2301 against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa.
    Bremner DA
    J Antimicrob Chemother; 1985 Oct; 16(4):457-61. PubMed ID: 3934129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro studies on SQ 26,776, a new monobactam antibiotic.
    Russell AD
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():81-8. PubMed ID: 6799485
    [No Abstract]   [Full Text] [Related]  

  • 14. In-vitro activity of SQ 26,776 against multiply-resistant enterobacteria--preliminary results.
    Acar JF; Kitzis MD; Goldstein FW
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():97-101. PubMed ID: 6276355
    [No Abstract]   [Full Text] [Related]  

  • 15. SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases.
    Phillips I; King A; Shannon K; Warren C
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():103-10. PubMed ID: 6976960
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of bacterial sensitivity in a Lambaréné hospital (Gabon)].
    Burchard GD; Wolff T
    Med Trop (Mars); 1985; 45(3):265-9. PubMed ID: 3934496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ro 13-9904 and GR 20263, two new cephalosporins with broad-spectrum activity: an in vitro comparison with other beta-lactam antibiotics.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1981 May; 7(5):515-20. PubMed ID: 6790506
    [No Abstract]   [Full Text] [Related]  

  • 18. Bactericidal and bacteriolytic activities of carumonam and its effect on bacterial morphology.
    Nakao M; Kondo M; Imada A
    J Antimicrob Chemother; 1986 Apr; 17(4):433-9. PubMed ID: 3086273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of Ro 09-1428, a novel cephalosporin with a catechol moiety.
    Qadri SM; Ayub A; Ueno Y; Saldin H
    Clin Ther; 1992; 14(4):562-9. PubMed ID: 1525790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
    Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
    Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.